Files

Download

Download Full Text (1.3 MB)

Date

2025

Abstract

Vermont has made significant progress since the start of the opioid crisis, with a growing number of patients receiving treatment for opioid use disorder. However, there have still been barriers to medication adherence in patients being treated with oral buprenorphine. Many of these difficulties have been addressed with the recent development of extended-release injectable buprenorphine. Given its recent emergence in health clinics, many patients aren’t aware of its availability, necessitating more accessible patient education materials.

Clinical Site

Mountain Community Health in Bristol, Vermont

Keywords

opioid use disorder, buprenorphine-ER

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Disciplines

Medical Education | Primary Care

Expanding Awareness of Buprenorphine-ER for Treatment of Opioid Use Disorder

Share

COinS